Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Bioactive Peptide-based Hydrogels for Alveolar Bone Regeneration

Objetivo

Tooth loss and the resulting alveolar bone resorption are highly prevalent conditions, particularly in aging populations and in patients suffering from inflammatory periodontal diseases. Dental implants are the preferred solution for replacing missing teeth; however, successful implantation requires sufficient alveolar bone volume. Bone resorption frequently leads to unfavorable conditions of the alveolar ridge, making socket preservation and bone augmentation procedures necessary to regenerate sufficient bone volume prior to dental implant placement. Current bone grafting approaches remain limited, particularly in elderly patients, diabetics, and smokers, highlighting the urgent need for improved regenerative strategies.
Here, we aim to develop a novel alveolar bone graft based on our patent-protected polysaccharide-peptide composite hydrogel, developed within the PersonalBone ERC-StG project. Unlike conventional bone graft materials, which primarily function as osteoconductive scaffolds, our technology is designed as an osteoinductive, immune-instructive biomaterial that actively recruits and modulates the host immune response to promote bone regeneration. By creating a bioactive microenvironment that stimulates immunomodulation and osteogenesis, this material represents a paradigm shift in alveolar bone regeneration strategies.
Within this ERC-PoC project, we will optimize the hydrogel formulation to achieve the mechanical stability required for socket preservation and its integration with clinically used bone graft particulates. The optimized composite graft will be evaluated for biocompatibility, bone regeneration capacity, and resorption kinetics in critical-size bone defect models in vivo, with clinical input from leading dentists. This technology has the potential to significantly advance current bone augmentation treatments and improve clinical outcomes for patients requiring dental implants.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2026-POC

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

TEL AVIV UNIVERSITY
Aportación neta de la UEn
€ 150 000,00
Coste total
Sin datos

Beneficiarios (1)